Literature DB >> 33272573

Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.

Lei Gu1, Zhefeng Guo2.   

Abstract

Formation of Aβ oligomers and fibrils plays a central role in the pathogenesis of Alzheimer's disease. There are two major forms of Aβ in the brain: Aβ42 and Aβ40. Aβ42 is the major component of the amyloid plaques, but the overall abundance of Aβ40 is several times that of Aβ42. In vitro experiments show that Aβ42 and Aβ40 affect each other's aggregation. In mouse models of Alzheimer's disease, overexpression of Aβ40 has been shown to reduce the plaque pathology, suggesting that Aβ42 and Aβ40 also interact in vivo. Here we address the question of whether Aβ42 and Aβ40 interact with each other in the formation of oligomers using electron paramagnetic resonance (EPR) spectroscopy. When the Aβ42 oligomers were formed using only spin-labeled Aβ42, the dipolar interaction between spin labels that are within 20 Å range broadened the EPR spectrum and reduced its amplitude. Oligomers formed with a mixture of spin-labeled Aβ42 and wild-type Aβ42 gave an EPR spectrum with higher amplitude due to weakened spin-spin interactions, suggesting molecular mixing of labeled and wild-type Aβ42. When spin-labeled Aβ42 and wild-type Aβ40 were mixed to form oligomers, the resulting EPR spectrum also showed reduced amplitude, suggesting that wild-type Aβ40 can also form oligomers with spin-labeled Aβ42. Therefore, our results suggest that Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions. Our results point to the importance of investigating Aβ42-Aβ40 interactions in the brain for a complete understanding of Alzheimer's pathogenesis and therapeutic interventions.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; Oligomers; Protein aggregation

Mesh:

Substances:

Year:  2020        PMID: 33272573      PMCID: PMC7785691          DOI: 10.1016/j.bbrc.2020.11.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides.

Authors:  Mohammad Shahnawaz; Arjun Thapa; Il-Seon Park
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

2.  Out-of-Register Parallel β-Sheets and Antiparallel β-Sheets Coexist in 150-kDa Oligomers Formed by Amyloid-β(1-42).

Authors:  Yuan Gao; Cong Guo; Jens O Watzlawik; Peter S Randolph; Elizabeth J Lee; Danting Huang; Scott M Stagg; Huan-Xiang Zhou; Terrone L Rosenberry; Anant K Paravastu
Journal:  J Mol Biol       Date:  2020-05-26       Impact factor: 5.469

3.  Structural insights into Aβ42 oligomers using site-directed spin labeling.

Authors:  Lei Gu; Cong Liu; Zhefeng Guo
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

4.  Using deubiquitylating enzymes as research tools.

Authors:  Rohan T Baker; Ann-Maree Catanzariti; Yamuna Karunasekara; Tatiana A Soboleva; Robert Sharwood; Spencer Whitney; Philip G Board
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

5.  Co-incorporation of A beta 40 and A beta 42 to form mixed pre-fibrillar aggregates.

Authors:  David Frost; Paul M Gorman; Christopher M Yip; Avijit Chakrabartty
Journal:  Eur J Biochem       Date:  2003-02

6.  Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.

Authors:  Ting Yang; Shaomin Li; Huixin Xu; Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurosci       Date:  2017-01-04       Impact factor: 6.167

7.  Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

Authors:  D L Miller; I A Papayannopoulos; J Styles; S A Bobin; Y Y Lin; K Biemann; K Iqbal
Journal:  Arch Biochem Biophys       Date:  1993-02-15       Impact factor: 4.013

8.  Mixing Aβ(1-40) and Aβ(1-42) peptides generates unique amyloid fibrils.

Authors:  Linda Cerofolini; Enrico Ravera; Sara Bologna; Thomas Wiglenda; Annett Böddrich; Bettina Purfürst; Iryna Benilova; Magdalena Korsak; Gianluca Gallo; Domenico Rizzo; Leonardo Gonnelli; Marco Fragai; Bart De Strooper; Erich E Wanker; Claudio Luchinat
Journal:  Chem Commun (Camb)       Date:  2020-07-06       Impact factor: 6.222

9.  A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity.

Authors:  Christine Xue; Yoon Kyung Lee; Joyce Tran; Dennis Chang; Zhefeng Guo
Journal:  R Soc Open Sci       Date:  2017-08-09       Impact factor: 2.963

Review 10.  The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.

Authors:  Erika N Cline; Maíra Assunção Bicca; Kirsten L Viola; William L Klein
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more
  4 in total

1.  Location of the cross-β structure in prion fibrils: A search by seeding and electron spin resonance spectroscopy.

Authors:  Brett K-Y Chu; Ruei-Fong Tsai; Chien-Lun Hung; Yun-Hsuan Kuo; Eric H-L Chen; Yun-Wei Chiang; Sunney I Chan; Rita P-Y Chen
Journal:  Protein Sci       Date:  2022-06       Impact factor: 6.993

2.  Lipid membranes induce structural conversion from amyloid oligomers to fibrils.

Authors:  Lei Gu; Zhefeng Guo
Journal:  Biochem Biophys Res Commun       Date:  2021-04-14       Impact factor: 3.322

3.  Design and Synthesis of 6-O-Phosphorylated Heparan Sulfate Oligosaccharides to Inhibit Amyloid β Aggregation.

Authors:  Kenji Uchimura; Kazuchika Nishitsuji; Li-Ting Chiu; Takashi Ohgita; Hiroyuki Saito; Fabrice Allain; Veeranjaneyulu Gannedi; Chi-Huey Wong; Shang-Cheng Hung
Journal:  Chembiochem       Date:  2022-06-16       Impact factor: 3.461

4.  A Multi-Chamber Paper-Based Platform for the Detection of Amyloid β Oligomers 42 via Copper-Enhanced Gold Immunoblotting.

Authors:  Le-Minh-Tu Phan; Sungbo Cho
Journal:  Biomolecules       Date:  2021-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.